Niagen Bioscience taps Evotec for NB4168 preclinical drug studies
Go back to Niagen Bioscience taps Evotec for NB4168 preclinical drug studies| EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) | Delayed: 1.73 -0.04 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.77 | 52 Week High | $16.39 | |||
| Open | $1.73 | 52 Week Low | $13.22 | |||
| Day High | $1.76 | P/E | N/A | |||
| Day Low | $1.72 | EPS | $-1.61 | |||
| Volume | 42,526 | |||||
| (NASDAQ: NAGE) | Delayed: 3.04 +0.01 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.03 | 52 Week High | $ | |||
| Open | $3.08 | 52 Week Low | $ | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $3.01 | EPS | $ | |||
| Volume | 321,474 | |||||
